The results demonstrated that PTBP1 expression was an independent prognostic factor for OS in glioma (hazard ratio (HR), 4.901; 95% confidence interval (CI), 2.778-8.645; and P < 0.001) (Table 3). Here, PTBP1 is linked to central nervous system cancer.